Dermata Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results

August 7, 2024 4:05 PM

Dermata Therapeutics, Inc. (Nasdaq:DRMA, DRMAW)("Dermata," or the "Company"), a late-stage biotechnology company focused on the treatment of medical and aesthetic skin diseases and conditions, today highlighted recent corporate progress and reported financial results for the second quarter ended June 30, 2024."We are excited to have enrolled over 50% of patients in our DMT310 Phase 3 STAR-1 trial, and we look forward to the second half of 2024...

Read more

Health eCareers and Society of Critical Care Medicine Announce New Collaboration  

August 7, 2024 12:45 PM

This collaboration provides career opportunities for critical care professionals by creating connections with employers seeking these highly sought-after and specialized skills.NEW YORK, NY / ACCESSWIRE / August 7, 2024 / Health eCareers, North America's leading recruitment and career network serving healthcare professionals, employers and associations, announced a new collaboration with the Society of Critical Care Medicine (SCCM) that improves...

Read more

NCQA Updates 2025 Credentialing Product Suite

August 7, 2024 12:00 PM

Updates ensure consistent, effective and diligent qualification verification processWASHINGTON, DC / ACCESSWIRE / August 7, 2024 / The National Committee for Quality Assurance (NCQA) announced updates to its Credentialing Product Suite, which provides a framework for healthcare organizations to implement industry best practices that help them accurately and efficiently credential and recredential licensed health care professionals to ensure an...

Read more

Hedden & Gunn Plastic Surgery Welcomes New Facial Plastic Surgeon, Dr. Beau Vandiver, Expanding Team Excellence

August 7, 2024 10:00 AM

BIRMINGHAM, AL / ACCESSWIRE / August 7, 2024 / Hedden & Gunn Plastic Surgery, a distinguished member of Ascend Aesthetic Partners, announces the appointment of Dr. Beau Vandiver as its newest facial plastic surgeon, effective July 31, 2024. Dr. Vandiver joins the esteemed practice, bringing a wealth of expertise and a dedication to advancing patient care in the Birmingham, Alabama area. Dr. Vandiver obtained his Doctor of Medicine degree from...

Read more

Applied DNA to Report Third Quarter Fiscal 2024 Financial Results on Thursday, August 8, 2024

August 7, 2024 8:00 AM

Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction (PCR)-based technologies, today announced that it will release its third quarter fiscal 2024 financial results after market close on Thursday, August 8, 2024. In conjunction with this announcement, Applied DNA management will host a conference call for analysts and members of the investment community starting at 4:30 p.m. ET the same...

Read more

Modular Medical Initiates Transfer of Manufacturing Operations to Phillips Medisize

August 7, 2024 8:00 AM

SAN DIEGO, CA / ACCESSWIRE / August 7, 2024 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), an insulin delivery system technology company preparing to launch the next generation of easy-to-use, prescribe and live with affordable insulin pump technology, today announced it has begun the transfer of its pilot line manufacturing operations to a Phillips Medisize manufacturing site in Queretaro, Mexico.Phillips Medisize,...

Read more

Evotec SE Reports First Half-year 2024 Results on 14 August 2024

August 7, 2024 7:15 AM

Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) will announce its financial results for the first half-year of 2024 on Wednesday, 14 August 2024.The Company is going to hold a conference call to discuss the results as well as provide an update on its performance. The conference call will be held in English.Webcast detailsDate: Wednesday, 14 August 2024Time: 2.00 pm CEST (01.00 pm BST, 08.00 am EDT)To join...

Read more

Opkit Rolls Out Back-of-Office Generative AI Call Center for Medical Practices With a Human-in-the-Loop Model

August 7, 2024 7:00 AM

Opkit, a generative AI call center for the healthcare industry, announces its HIPAA-compliant, AI-powered software platform that automates back office phone calls for medical clinics. The platform manages outbound calls to payers for insurance verification, claims, and prior authorization, as well as calls to pharmacies for prescription checks, and calls to collect medical records. Opkit's AI solution is supported by a human-in-the-loop to...

Read more

LPW Training Services Named 2024 Best Company for Women to Work

August 7, 2024 7:00 AM

Women's Choice Award® Names LPW Training Services a 2024 Best Companies to Work for WomenSOMERVILLE, NJ / ACCESSWIRE / August 7, 2024 / LPW Training Services was recognized with three awards as a 2024 Best Companies to Work for Women, Inclusion, and Millennials. The Women's Choice Award is the only distinction that identifies the nation's best companies to work for based on robust criteria. "As a minority and women-owned company, LPW values...

Read more

Interactive Wound Dressing Market Is Expected to Reach USD 9.0 Billion by 2034 and Grow at a Compound Annual Growth Rate of 5.6% | FMI Inc.

August 7, 2024 5:00 AM

According to Future Market Insights (FMI), the global interactive wound dressing market is expected to grow from USD 5.2 billion in 2024 to USD 9.0 billion by 2034. By 2034, the market is projected to surge at a 5.6% CAGR. Rising long-term injuries, a growing senior citizen base, technological advancements in dressings, and increased consumer awareness are projected to fuel the market. The United Nations predicts that the global senior...

Read more

LICORbio and Bioz Collaborate to Elevate Scientific Insights With Advanced Publication Data Integration

August 7, 2024 4:00 AM

PALO ALTO, CA / ACCESSWIRE / August 7, 2024 / Bioz, Inc., a pioneer in AI-driven research solutions, is excited to announce its collaboration with LICORbio, a leading provider of innovative solutions for life science research in both the instrument and reagent space. LICORbio's dedication to providing high-quality products across diverse scientific fields integrates seamlessly with Bioz's goal of improving research outcomes through data-driven...

Read more

New Results from AlzeCure's Pain Project TrkA-NAM Presented at the Pain Conference IASP 2024

August 7, 2024 2:20 AM

STOCKHOLM, SE / ACCESSWIRE / August 07, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced that its presentation about the preclinical project TrkA-NAM against osteoarthritis pain and other severe pain conditions, which is presented at the IASP 2024 World...

Read more

NHI Announces Third Quarter 2024 Dividend

August 6, 2024 4:15 PM

National Health Investors, Inc. (NYSE:NHI) announced today that it will pay its third quarter dividend of $0.90 per common share on November 1, 2024 to stockholders of record as of September 27, 2024.About NHIIncorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven...

Read more

NHI Issues Investor Update

August 6, 2024 4:10 PM

MURFREESBORO, TN / ACCESSWIRE / August 6, 2024 / National Health Investors, Inc. (NYSE:NHI) has issued the following investor update which can be found at:NHI | Presentations and Webcasts (nhireit.com)Incorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and...

Read more

NHI Announces Second Quarter 2024 Results

August 6, 2024 4:05 PM

National Health Investors, Inc. (NYSE:NHI) announced today its results for the three and six months ended June 30, 2024.Financial Results and Recent EventsNet income attributable to common stockholders per diluted common share for the three months ended June 30, 2024 was $0.81 compared to $0.92 during the same period in the prior year. Net income attributable to common stockholders per diluted common share for the six months ended June 30, 2024...

Read more

Rymedi Partners with Incora Health

August 6, 2024 11:45 AM

GREENVILLE, SC / ACCESSWIRE / August 6, 2024 / Rymedi and Incora Health announce their strategic partnership aimed at improving women's health. The Incora Health Earring, designed to monitor women's whole health through their unique menstrual cycles, will leverage Rymedi's blockchain-enabled patient and population health data platform to serve as a comprehensive digital patient and results management tool. Rymedi's patented technology separates...

Read more

VivaWell and Keyzell Holding Announce Strategic Global Cooperation to Develop Innovative AI Health Solutions

August 6, 2024 9:10 AM

MEXICO CITY, MEXICO / ACCESSWIRE / August 6, 2024 / VivaWell, the pioneering healthtech transforming healthcare in Mexico and Argentina, proudly announces a strategic global cooperation agreement with Keyzell Holding, the biotech leader recognized for its groundbreaking advancements in precision medicine that enhance patient quality of life and save lives. This agreement marks the beginning of a close collaboration between both companies, aimed...

Read more

Cosmos Health Reports Full Year 2023 Results: Revenue Increases to $53.4M, or 6% YoY; Stockholders' Equity Remains Near Record Highs at $36M, or $2.25 per Share

August 6, 2024 9:00 AM

Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, today reported financial results for the full year ended December 31, 2023.Full Year 2023 Financial HighlightsIncome Statement:Revenue...

Read more

Biopharmaceutical Contract Manufacturing Market Is Expected to Reach USD 25.1 Billion by 2034 And Grow at A CAGR of 8.8% | Future Market Insights Inc.

August 6, 2024 8:30 AM

The biopharmaceutical contract manufacturing market is expected to be valued at USD 10.7 billion in 2024. The market is projected to progress at a CAGR of 8.8% and reach a market value of USD 25.1 billion by 2034. The market is witnessing a surge in demand for various reasons. Biologics are complex molecules that require specialized expertise for their manufacture. Therefore, pharmaceutical companies prefer outsourcing their manufacturing...

Read more

Aytu BioPharma Announces Sale of Consumer Health Business Following Wind Down of Consumer Health Operations

August 6, 2024 8:00 AM

Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced that following the wind down of operations, it has entered into a definitive agreement to divest its Consumer Health (a/k/a Innovus Pharmaceuticals) business to a private, e-commerce focused company. The divested business encompasses the established e-commerce platform, certain inventory and...

Read more